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1. Introduction 
Postprandial hypoglycemia is a syndrome secondary to disorders in which hypoglycemia is 
manifested within 5 hours after a meal (1). It is classified into two types depending on the 
time of occurrence, i.e., ‘early,’ with onset within 2 hours, and ‘late,’ occurring between 3 
and 5 hours after a meal. The early variety is thought to be secondary to abnormally rapid 
gastric emptying, whereas late postprandial hypoglycemia is frequently deemed to be a 
precursor to the onset of type 2 diabetes mellitus (1-14). Causes of late postprandial 
hypoglycemia also include disorders manifesting as fasting hypoglycemia, such as factitious 
hypoglycemia due to exogenous insulin administration or surreptitious use of insulin 
secretogogues, e.g, sulfonylureas, glinides, or other hypoglycemic agents, insulinoma, islet 
cell hyperplasia, autoimmune hyperinsulinemia, hyperinsulinemia caused by drugs and 
toxins, excess of circulating IGF2 secreted by non-pancreatic tumors, adrenal or pituitary 
hypofunction, advanced liver dysfunction, and end-stage renal disease(15-29 ) Several rare 
disorders, including some congenital syndromes, e.g., glycogen storage disorders, can also 
cause late postprandial hypoglycemia(30). In contrast, early postprandial hypoglycemia 
occurs only postprandially and usually is noted in subjects following upper gastrointestinal 
surgery, including bariatric procedures, hyperthyroidism, etc (1,21,26,31,32). In some 
subjects, it occurs without an obvious apparent cause and is therefore termed ‘idiopathic 
reactive hypoglycemia.’ Arguably, many endocrinologists approve of this syndrome, 
whereas others question its existence and call it ‘postprandial syndrome,’ probably because 
of the debate over the diagnosis of hypoglycemia itself (8,21,29).  
Hypoglycemia presents with manifestations of increased sympathetic activity, i.e., anxiety, 
jitters, palpitations, dizziness, tremor, weakness, drenching perspiration, hunger, systolic 
hypertension, mydriasis, etc., attributed to prompt release of catecholamines, which is 
documented to occur with a fall of blood sugar to lower than 70 mg /dl  (29,34,35). 
Manifestations more seriously detrimental to life, i.e., of a neuroglycopenic nature, include 
convulsion, confusion, coma, or other altered states of consciousness, and transient CNS 
manifestations, including hemiparesis. Cardiac manifestations include symptomatic 
coronary artery disease, i.e., angina pectoris, arrhythmias, or even myocardial infarction 
following extreme lowering of blood sugars, usually to concentrations below 50 mg/dl (35). 
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Few authorities still believe that the onset of manifestations of exaggerated sympathetic 
activity may be dependent on the rapidity of rate of fall in blood glucose irrespective of the 
exact concentration, although several studies have refuted this hypothesis.  
Therefore, in subjects with diabetes, hypoglycemia is deemed to occur with the onset of 
symptoms even when the blood sugar is between 50 and 70 mg/dl. Moreover, blood sugars 
lower than 70 mg/dl in the absence of manifestations of sympathetic overactivity are also 
defined as hypoglycemia and the subject is deemed to manifest hypoglycemia unawareness 
(36-38). Finally, all efforts are made to prevent ‘hypoglycemia’ in both these circumstances 
frequently by altering the treatment plan. In contrast, several authorities promote that the 
diagnosis of hypoglycemia should be made in the presence of blood sugar <50 mg/dl and 
that too only if criteria for Whipple’s triad are fulfilled (39). The triad consists of 
documentation of a blood sugar <50 mg/dl accompanied by symptoms of hypoglycemia, 
and resolution of symptoms by inducing a rise in blood sugar by either ingestion of sugar or 
a meal, or iv administration of glucose. 
Thus, according to these authors, subjects with documentation of a blood sugar < 50 mg/dl, 
after an overnight fast, postprandially, or randomly, deserve evaluation in the absence of 
diabetes mellitus only if the low blood sugar is accompanied by symptoms (21,26,29),. The 
recommendation is totally different in the presence of diabetes. In subjects with diabetes, a 
thorough assessment of hypoglycemic symptoms and even asymptomatic low blood sugar 
is recommended. Therefore, in the absence of symptoms, in non-diabetic subjects, a blood 
sugar < 50 mg/dl is not defined as a syndrome of ‘hypoglycemia’ by these authors. 
However, this concept is in stark contrast to the tenet of ethical medical practice to define 
and treat disorders with definite documentation of metabolic abnormalities despite the 
absence of  symptoms, e.g., hyperglycemia, hypercalcemia, changes in sodium and 
potassium concentrations, and many other medical disorders, including subclinical hypo 
and hyperthyroidism. This practice is obviously prudent in the light of clear documentation 
of increased morbidity and even mortality of subclinical disorders, especially with lack of 
restoration of the normal state. Furthermore, restoring and preserving the normal state with 
appropriate treatment is also documented to improve the quality of life in these subjects 
manifesting subclinical disorders. Therefore, it is difficult to fathom why the same principle 
is not applied in the management of well documented postprandial hypoglycemia in the 
absence of typical symptoms or frequently even in the presence of characteristic 
manifestations. 
We firmly believe that postprandial hypoglycemia is a ‘true’ disorder with a distinct 
deterioration in quality of life, including attention deficit and loss of productivity (1,9 -
14,40),. Moreover, a cause of the abnormality is easily determined by a detailed history, a 
thorough physical examination, and simple laboratory testing. A history of upper 
gastrointestinal surgery for esophageal and gastric diseases, bariatric procedures, symptoms 
of hyperthyroidism, the timing of the occurrence of symptoms following a meal, i.e., ‘early’ 
or ‘late’ onset, dietary pattern provoking symptoms, i.e., high carbohydrate content or 
ingestion of simple sugars, changes in body weight, use of certain drugs, history of 
gestational diabetes; all provide clues to indicate a specific diagnosis. Family history of type 
2 diabetes mellitus is important information as well. Similarly, a thorough physical 
examination may indicate the presence of a specific disorder. Finally, the determination of 
appropriate laboratory tests after an overnight fast and at frequent (30 minute) intervals, up 
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to 5 hours or at the onset of symptoms of hypoglycemia following ingestion of a mixed meal 
or glucose (OGGT) often clinches the diagnosis. 
The occurrence of postprandial hypoglycemia within 2 hours is attributed to an exaggerated 
insulin response to markedly elevated plasma glucose levels within 15-30 minutes caused by 
a prompt absorption of carbohydrate content, especially the simple variety due to a super 
fast transit of  an ingested meal across the  stomach as initially documented in subjects 
undergoing gastric surgery e.g. partial or total gastrectomy for several decades and more 
recently in morbidly obese subjects undergoing gastric bypass surgery(1,54,8,20,21,26) In 
fact ,we believe that persistent occurrence of hypoglycemia irrespective of timing of the 
meal during the later years following gastric bypass surgery may attributed to repeated 
frequent postprandial stimulation of pancreatic beta cells ultimately leading to autonomous 
beta cell hyperplasia requiring excision (26) .Surgery may be prevented by appropriate 
dietary changes as well as a prompt therapy with medications during the initial period 
following a bariatric procedure (42-47)  
In the absence of documentation of a known disorder, early postprandial hypoglycemia is 
also termed ‘Idiopathic reactive hypoglycemia’ by some and ‘postprandial syndrome’ by 
others. We firmly believe that ‘Idiopathic reactive hypoglycemia’ is a genuine disorder, 
since several pathophysiologic mechanisms have been implicated (2-14).The occurrence of 
hypoglycemia in this disorder has been attributed to rapid gastric emptying secondary to 
lack of rise in Gastric Inhibitory Polypeptide following an ingestion of a meal or altered 
secretion of other gastrointestinal motility factors,e.g.Motilin, Bombesin etc(1-4) Remission 
of hypoglycemia by inhibition of gastric emptying by use of drugs with ability to induce 
cholinergic blockade enhances this hypothesis. Alternatively, altered function of both 
pancreatic alpha and beta cells has also been invoked. We have documented enhanced 1st or 
early phase insulin secretion within 30-60  minutes in response to   glucose ingestion as well 
as aberrant  pancreatic alpha cell function in this syndrome (Table 1).   plasma glucagon is 
elevated after an overnight fast in comparison to normal subjects despite presence of normal 
glucose concentration indicating glucagon insensitivity (Table1). However,  inhibited 
glucagon decline with initial hyperglycemia and a blunted rise following onset of 
hypoglycemia documents altered glucagon secretion in this syndrome.(Figure1) Impaired 
regulation of glucagon in this syndrome is further confirmed by decline in glucagon 
response  following oral administration of a protein meal (figure 2), a well established  
stimulus for facilitating glucagon secretion and release by pancreatic alpha cells(41).This 
altered pancreatic alpha and beta cell function is also documented in several other studies 
(7,9,1,33,40). Finally, the presence of the disorder is further enhanced by documentation of 
remission of symptoms and hypoglycemia by appropriate intervention with several 
protocols, including lifestyle changes with use of a diet with tolerated amount of fiber as 
well as high protein, low carbohydrate contents, avoidance of ingestion of simple or free 
sugars, and frequent small feedings (1,5,14 ). Moreover, in the absence of total remission 
with these lifestyle changes, several drugs have been successfully used. These include 
agents, e.g. atropine derivatives which delay gastric emptying by cholinergic blockade as 
mentioned earlier, drugs inhibiting conversion of complex to simple 
carbohydrates,e.g.alpha-glucosidase inhibitors, medications altering insulin secretion 
e.g.calcium channel blockers, or drugs possessing all of these properties, e.g. octreotide 
(3,42-47). In contrast, ‘late reactive or postrprandial  hypoglycemia’documented in ‘impaired 
glucose tolerance’, a prediabetic state is induced by exaggerated 2nd or late phase insulin 
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secretion occurring between 90 -120 minutes induced by marked elevated  plasma glucose 
concentration at 60-90 minutes due to inhibition of 1`st phase insulin secretion following a 
meal or oral administration of glucose (48-52)).Moreover, hypoglycemia in this disorder also 
is remediable by appropriate lifestyle changes and certain drugs (53). 
Therefore, A subject manifesting symptoms of hypoglycemia following a meal must be 
evaluated by a detailed history, a thorough physical examination and appropriate 
laboratory testing. First and foremost, the presence of low blood sugar level, e.g < 6O mg/dl 
must be documented with accompanying hypoglycemic symptoms. The diagnosis could be 
further established by assessment of blood sugars following ingestion of a mixed meal or 
oral administration of glucose. Once the diagnosis is confirmed, the appropriate treatment 
should be provided as it distinctly improves quality of life. Early postprandial 
hypoglycemia with onset within 2 hours may be treated with life style dietary changes 
initially. The drugs may be used  later as an adjunctive therapy if dietary manipulations fail 
to attain  and maintain remission. The documentation  of late  reactive hypoglycemia 
indicates a presence of ‘Prediabetes’ which also may be managed with lifestyle changes, e.g. 
diet and exercise, to achieve weight loss especially in the obese subjects as well as with 
drugs, e.g. Metformin in subjects with increased risk for progression to Diabetes as 
recommended by American Diabetes Association(48),  
Therefore, in the final analysis, it is imperative to consider the presence of postprandial 
hypoglycemia as a disorder and conduct an appropriate evaluation and provide suitable 
therapeutic strategies.  
 
 
 
 
 
Group 
Age 
(yr) 
Body 
Weight 
(kg) 
Fasting 
Plasma 
Glucose 
(mmol/L)* 
Fasting 
Plasma 
Insulin 
(mU/L)* 
Fasting 
Plasma 
Glucagon 
(ng/L)* 
IHR 37±6 59±8 4.9±0.2 7±2 347±83† 
Normal 34±5 62±7 5.2±0.1 6±1 135±20 
 
 
* The average of 2 values in individual subjects, 1 during the OGTT and the other during the protein 
meal study, was used for calculation. 
† P< .025, IRH v normal. 
Reprinted from reference 12, with permission  
 
 
Table 1. Fasting Plasma Glucose, Insulin,and Glucagon Levels in Five Subjects With IRH and 
Six Normal Subjects. 
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Fig. 1. Glucose, insulin, and glucagon responses to oral ingestion of 100 g glucose(OGTT) in 
5 subjects with IRH (▲) and 6 normal subjects () * P< .01 v normal. Reprinted from 
reference 12, with permission 
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Fig. 2. Glucose, insulin, and glucagon responses to oral ingestion of a protein meal in 5 
subjects with IRH (▲) and 6 normal subjects (). * < .05 v normal. † P< .01 IRH. Reprinted 
from reference 12, with permission  
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